Neuroscience and Behavioral Physiology

, Volume 40, Issue 3, pp 351–355 | Cite as

Principles of Medical Care for Children with Attention Deficit Hyperactivity Disorder

  • L. S. Chutko
  • R. G. Yur’eva
  • S. Yu. Surushkina
  • I. S. Nikishena
  • I. S. Yakovenko
  • T. I. Anisimova
  • K. A. Aitbekov


Attention Deficit Atomoxetine Comorbid Disorder Dyslexia Oppositional Defiant Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    N. N. Zavadenko, Impaired Formation of Oral and Written Speech in Children. Medication-Based Correction. Guidelines for Doctors [in Russian], RKI Sovero Press, Moscow (2003).Google Scholar
  2. 2.
    N. N. Zavadenko, Hyperactivity and Attention Disorder in Children. A Textbook [in Russian], Akademiya, Moscow (2005).Google Scholar
  3. 3.
    I. Lesny, Clinical Study Methods in Pediatric Neurology [Russian translation], Meditsina, Moscow (1987).Google Scholar
  4. 4.
    E. K. Lyutova and G. B. Monina, Training for Effective Interaction with Children [in Russian], Rech, St. Petersburg (2000).Google Scholar
  5. 5.
    E. Mesch and D. Wolf, Pediatric Pathopsychology: Impairments to Mental Functions in Children [Russian translation], Praim-Evroznak, St. Petersburg (2003).Google Scholar
  6. 6.
    I. S. Nikishena, V. A. Ponomarev, V. A. Grin’-Yatsenko, and Yu. D. Kropotov, “Topography of changes in EEG spectral power during sessions of biological BETA rhythm feedback,” Fiziol. Cheloveka, 30, No. 3, 13–18 (2004).Google Scholar
  7. 7.
    L. S. Chutko, Attention Deficit Hyperactivity Disorder and Accompanying Disorders [in Russian], Khoka, St. Petersburg (2007).Google Scholar
  8. 8.
    L. S. Chutko and A. M. Livinskaya, Specific Disorders of Speech Development in Children. A Textbook [in Russian], St. Petersburg (2006).Google Scholar
  9. 9.
    L. S. Chutko, S. Yu. Surushkina, I. S. Nikishena, et al., “Treatment of attention deficit disorder with comorbid tic hyperkinesias,” Zh. Nevrol. Psikhiat., 108, No. 2, 66–68.Google Scholar
  10. 10.
    L. S. Chutko, K. A. Aitbekov, O. V. Lapshina, et al., “Comorbid anxiety disorders in attention deficit hyperactivity disorder,” Zh. Nevrol. Psikhiat., 108, No. 3, 49–52 (2008).Google Scholar
  11. 11.
    R. G. Yur’eva, Scientifically Based Organization of Rehabilitation Therapy of Children with Limited Abilities [in Russian], Author’s Abstract of Thesis for Doctorate in Medical Sciences, St. Petersburg (2007).Google Scholar
  12. 12.
    A. J. Allen, R. M. Kurlan, D. L. Gilbert, et al., “Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders,” Neurology, 65, No. 12, 1941–1949 (2005).CrossRefPubMedGoogle Scholar
  13. 13.
    R. A. Barkley, “Attention Deficit Disorder with Hyperactivity: A Handbook for Diagnosis and Treatment, New York (1998).Google Scholar
  14. 14.
    J. Barton, Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder,” Arch. Dis. Child., 90, Supplement 1, 26–29 (2005).CrossRefGoogle Scholar
  15. 15.
    R. T. Brown, W. S. Freeman, J. M. Perrin, et al., “Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings,” Pediatrics, 114, No. 2, 511–512 (2004).CrossRefGoogle Scholar
  16. 16.
    A. R. Clarke, R. J. Barry, R. McCarthy, and M. Selikowitz, “EECdefined subtypes of children with attention-deficit/hyperactivity disorder,” Clin. Neurophysiol., 112, No. 11, 2098–2105 (2001).CrossRefPubMedGoogle Scholar
  17. 17.
    M. B. Dencla, “Revised neurological examination for subtle signs,” Psychopharm. Bull., 21, 773–789 (1985).Google Scholar
  18. 18.
    Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington (1994), 4th edition.Google Scholar
  19. 19.
    S. V. Faraone, J. Sergent, C. Gillberg, and J. Biederman, “The worldwide prevalence of ADHD: is it an American condition?” World Psychiat., 2, No. 2, 104–113 (2003).Google Scholar
  20. 20.
    L. Greenberg and I. Waldmant, “Developmental normative data on the test of variables of attention (TOVA),” Child Psychiat., 34, No. 6, 1019–1030 (1993).CrossRefGoogle Scholar
  21. 21.
    P. Hazell, S. Zhang, T. Wolanczyk, et al., “Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder,” Eur. Child Adolesc. Psychiat., 15, No. 2, 105–110 (2006).CrossRefGoogle Scholar
  22. 22.
    D. K. Kelsey, C. R. Sumner, C. D. Casat, et al., “Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial,” Pediatrics, 114, No. 1, 1–8 (2004).CrossRefGoogle Scholar
  23. 23.
    J. F. Lubar, “Discourse on the development of EEC diagnostics and biofeedback treatment for attention-deficit/hyperactivity disorders,” Biofeedback Self-Regulation, 16, 201–203 (1991).CrossRefGoogle Scholar
  24. 24.
    C. A. Mann, J. F. Lubar, A. W. Zimmerman, et al., “Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: Controlled study with clinical implications,” Pediat. Neurol., 8, 30–36 (1992).CrossRefPubMedGoogle Scholar
  25. 25.
    D. Michelson, A. J. Allen, J. Busner, et al., “Once daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomised, placebo-controlled study,” Amer. J. Psychiat., 159, 1896–1901 (2002).CrossRefPubMedGoogle Scholar
  26. 26.
    V. J. Monastra, J. F. Lubar, and M. Linden, “The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies,” Neuropsychology, 15, No. 1, 136–144 (2001).CrossRefPubMedGoogle Scholar
  27. 27.
    M. B. Sterman, “Physiological origins and functional correlates of EEG rhythmic activities: implications for self-regulation,” Biofeedback Self-Regulation, 21, 3–33 (1996).CrossRefGoogle Scholar
  28. 28.
    J. M. Swanson, School-Based Assessments and Interventions for ADD Students, K. C. Publishing, Irvine (1992).Google Scholar
  29. 29.
    M. Weiss, R. Tannock, C. Kratochvil, et al., “Placebo-controlled study of once-daily atomoxetine in the school setting,” Eur. Neuropsychopharmacol., 13, Supplement 4, 456–457 (2003).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2010

Authors and Affiliations

  • L. S. Chutko
    • 1
    • 2
  • R. G. Yur’eva
    • 1
    • 2
  • S. Yu. Surushkina
    • 1
    • 2
  • I. S. Nikishena
    • 1
    • 2
  • I. S. Yakovenko
    • 1
    • 2
  • T. I. Anisimova
    • 1
    • 2
  • K. A. Aitbekov
    • 1
    • 2
  1. 1.Institute of the Human BrainRussian Academy of SciencesSt. PetersburgRussia
  2. 2.City Center for the Rehabilitation Treatment of Children with Psychoneurological ImpairmentsSt. PetersburgRussia

Personalised recommendations